Gemcitabine is active against clinical multiresistant Staphylococcus aureus strains and is synergistic with gentamicin

International Journal of Antimicrobial Agents

Volumn 39, Issue 5, 2012, Pages 444-447

  Jordheim, Lars Petter ^a,b,c   Ben Larbi, Sabrina ^a,b,d   Fendrich, Olivier ^a,b,d   Ducrot, Claire ^a,b,d   Bergeron, Emmanuelle ^a,b,d   Dumontet, Charles ^a,b,c   Freney, Jean ^a,b,d   Doléans Jordheim, Anne ^a,b,d  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d University of Lyon   (France)

Author keywords

Antibiotic; Drug repositioning; Gemcitabine; Resistance; Staphylococcus aureus

Indexed keywords

GEMCITABINE; GENTAMICIN; NUCLEOSIDE ANALOG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG SCREENING; GENE MUTATION; GENE SEQUENCE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOSIDE KINASE GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DEOXYCYTIDINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84859428885     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.01.019     Document Type: Article

References (11)

1. G.M. Rossolini, and E. Mantengoli Antimicrobial resistance in Europe and its potential impact on empirical therapy Clin Microbiol Infect 14 Suppl. 6 2008 2 8 (Pubitemid 352749376)
2. T.T. Ashburn, and K.B. Thor Drug repositioning: identifying and developing new uses for existing drugs Nat Rev Drug Discov 3 2004 673 683 (Pubitemid 39173508)
3. C.L. Clouser, C.M. Holtz, M. Mullett, D.L. Crankshaw, J.E. Briggs, and J. Chauhan Analysis of the ex vivo and in vivo antiretroviral activity of gemcitabine PLoS One 6 2011 e15840
4. M.P. Sandrini, A.R. Clausen, S.L. On, F.M. Aarestrup, B. Munch-Petersen, and J. Piskur Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner J Antimicrob Chemother 60 2007 510 520 (Pubitemid 47299864)
5. M.P. Sandrini, O. Shannon, A.R. Clausen, L. Bjorck, and J. Piskur Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria Antimicrob Agents Chemother 51 2007 2726 2732 (Pubitemid 47206206)
6. A. Doleans-Jordheim, E. Bergeron, F. Bereyziat, S. Ben-Larbi, O. Dumitrescu, and M.A. Mazoyer Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains Eur J Clin Microbiol Infect Dis 30 2011 1249 1256
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 8th ed. Document M7-A8. Wayne, PA: CLSI; 2009.
8. R. Grunewald, H. Kantarjian, M. Du, K. Faucher, P. Tarassoff, and W. Plunkett Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study J Clin Oncol 10 1992 406 413
9. J.L. Abbruzzese, R. Grunewald, E.A. Weeks, D. Gravel, T. Adams, and B. Nowak A phase I clinical, plasma, and cellular pharmacology study of gemcitabine J Clin Oncol 9 1991 491 498
10. L. Drago, E. De Vecchi, L. Nicola, and M.R. Gismondo In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections BMC Infect Dis 7 2007 111
11. L.P. Jordheim, C.M. Galmarini, and C. Dumontet Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells Cancer Chemother Pharmacol 58 2006 547 554 (Pubitemid 43999805)